OMCL Omnicell
$35.46 +2.37%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+2.37%
YTD
+17.20%
P/E
39.36
P/B
1.65
ROE
3.1%
Div yield
—
Beta
0.97
Market cap
$1.5B
RSI (14)
59
Next earnings
Oct 28, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$34.95
Close
$35.46
VWAP (n/a)
—
Day high
$35.56
Day low
$34.24
Volume
634K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
1 Healthcare Stock with Exciting Potential and 2 We Find Risky
Yahoo Finance · Oct 6
Healthcare Technology for Providers Stocks Q2 Recap: Benchmarking Omnicell (NASDAQ:OMCL)
Yahoo Finance · Oct 5
Omnicell (OMCL) Stock Trades Below Fair Value After A 78% Slump
Yahoo Finance · Sep 22
3 Reasons OMCL is Risky and 1 Stock to Buy Instead
Yahoo Finance · Sep 21
TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations
Yahoo Finance · Sep 3
Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference
Yahoo Finance · Aug 31
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Aug 5, 2026 View → 8-K Jul 30, 2026 View → 8-K Jul 1, 2026 View → 8-K May 26, 2026 View → 10-Q May 6, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell OMCL. Try it in the Lab to size a position and see the risk.